INCYTE CORPORATION

Biopharmaceutical Company

1801 Augustine Cut-Off Wilmington DE 19803, Wilmington, DE  ·  MELISSA BANASHAK

Filings
26
Clients
1
Total Income
Years Active
2021–2026

Filings

Year Client Period Income Expenses Doc
2026 INCYTE CORPORATION 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$480,000
2025 INCYTE CORPORATION 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$530,000
2025 INCYTE CORPORATION 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$330,000
2025 INCYTE CORPORATION 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$520,000
2025 INCYTE CORPORATION 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$240,000
2024 INCYTE CORPORATION 4th Quarter (Oct 1 - Dec 31)
AMENDED
$350,000
2024 INCYTE CORPORATION 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$240,000
2024 INCYTE CORPORATION 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$220,000
2024 INCYTE CORPORATION 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$300,000
2024 INCYTE CORPORATION 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$200,000
Page 1 of 3  ·  26 filings Next

Clients Represented

ClientFilingsTotal Income
INCYTE CORPORATION 26

Lobbyists

NameDisclosed Prior Position
MELISSA WIER BANASHAK
JENNIFER BARBLAN Chief Oversight Counsel, Counsel, House Energy and Commerce Committee; Senior Counsel, Counsel, House Oversight and Gov…